Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Cationic, amphiphilic copolymer micelles as nucleic acid carriers for enhanced transfection in rat spinal cord

Cationic, amphiphilic copolymer micelles as nucleic acid carriers for enhanced transfection in rat spinal cord

Acta Biomater, 2016 · DOI: 10.1016/j.actbio.2016.02.013 · Published: April 15, 2016

PharmacologyGeneticsBiomedical

Simple Explanation

Spinal cord injuries often result in permanent motor and sensory deficits due to the limited regenerative capacity of the adult central nervous system. Nucleic acid-based therapies are a promising strategy for delivering bioactive molecules that can promote axonal regeneration. The study introduces a novel nonviral vector, poly (lactide-co-glycolide)-graft-polyethylenimine (PgP) micelle, capable of efficiently delivering plasmid DNA (pDNA) and siRNA in the presence of serum. The developed PgP copolymer enhances transfection and reduces cytotoxicity in neural cells both in vitro and in vivo, suggesting its potential as a nonviral vector for therapeutic nucleic acid delivery aimed at neural regeneration.

Study Duration
7 days in vivo
Participants
Sprague Dawley rats (male, 200 gm), C6 cells, B35 cells, and primary E8 chick forebrain neurons
Evidence Level
Not specified

Key Findings

  • 1
    PgP micelles efficiently transfect pDNA and siRNA in the presence of 10% serum in neuroglioma (C6) cells, neuroblastoma (B35) cells, and primary E8 chick forebrain neurons (CFN).
  • 2
    PgP provides high-level transgene expression in the rat spinal cord in vivo, substantially greater than that attained with bPEI.
  • 3
    PgP/pβ-Gal achieved substantial transfection in the injection site and surrounding neural tissue that was substantially higher than bPEI/pβ-Gal or naked pβ-Gal controls.

Research Summary

The study introduces a novel cationic amphiphilic copolymer, poly (lactide-co-glycolide)-graft-polyethylenimine (PgP), as an efficient nonviral vector for nucleic acid delivery to the spinal cord. PgP micelles demonstrated improved transfection efficiency and reduced cytotoxicity in vitro in the presence of serum, as well as enhanced in vivo transfection of neural cells compared to conventional bPEI. The in vivo results showed that PgP/pβ-Gal achieved substantial transfection in the rat spinal cord, significantly outperforming bPEI/pβ-Gal and naked pβ-Gal controls.

Practical Implications

Therapeutic Potential

PgP may be a useful therapeutic nucleic acids delivery carrier for the treatment of spinal cord injury, as well as other forms of CNS trauma and neurodegenerative diseases.

Multifunctional Delivery Systems

Future studies will extend the capabilities of PgP through conjugation of neuron-specific targeting ligands for siRNA delivery and hydrophobic drug loading within the micelle core.

Combinatorial Therapy

PgP's ability to deliver both genes and drugs makes it a promising candidate for combinatorial therapy strategies in treating SCI.

Study Limitations

  • 1
    The 10% serum-containing medium used in vitro does not fully replicate the protein and salt concentrations of blood or cerebrospinal fluid.
  • 2
    Longer-term studies are required to fully assess the stability of PgP/pDNA vectors.
  • 3
    Further studies are needed to fully characterize the effect of HLB on transfection efficiency and its mechanistic basis.

Your Feedback

Was this summary helpful?

Back to Pharmacology